SEC Form 4 · accession 0001209191-18-022939
CONCERT PHARMACEUTICALS, INC. · CNCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
James V Cassella
Officer — Chief Development Officer
Period of report
Mar 31, 2018
Accepted (ET)
Apr 3, 2018 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 31, 2018 | F | 4,418 | $22.90 | D | 55,582 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Transaction represents withholding of shares to satisfy tax withholding obligations upon the vesting of restricted stock units.